- Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib. Sherbenou, D.W., Wong, M.J., Humayun, A., McGreevey, L.S., Harrell, P., Yang, R., Mauro, M., Heinrich, M.C., Press, R.D., Druker, B.J., Deininger, M.W. Leukemia (2007)